LRG1 levels are elevated in the blood of patients with non-small-cell lung [42], ovarian [43], colorectal cancer [44], and gliomas [45] through TGF-β signaling, which promotes endothelial cell proliferation and angiogenesis [46]. Here, LRG1 is linked to glioma.